De Ying Cao
Director/Board Member at HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
De Ying Cao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Director/Board Member | 2021-12-29 | - |
| Independent Dir/Board Member | 2021-12-29 | - | |
| Hebei Medical University | Corporate Officer/Principal | 2011-08-07 | - |
Hebei Yipin Pharmaceutical Co., Ltd.
 Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Director/Board Member | 2021-04-30 | - |
| Independent Dir/Board Member | 2021-04-30 | - |
Career history of De Ying Cao
Former positions of De Ying Cao
| Companies | Position | Start | End |
|---|---|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Director/Board Member | 2011-08-07 | - |
| Independent Dir/Board Member | 2011-08-07 | - |
Statistics
International
| China | 4 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Stock Market
- Insiders
- De Ying Cao
- Experience
